Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
Last updated: 2026-02-04 02:57:54 ET
The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic compe...
Nirmala Sitharaman sees small improvements in fiscal deficit and debt-to-GDP ratio
The European economy recorded modest growth at the end of last year, overcoming higher U.S. tariffs
Port Houston posted record container and truck volumes in 2025, while Port of Corpus Christi saw modest overall declines in cargo traffic. The post Po...